Washington
Post notes crucial interview which triggered Wakefield investigation
This page
is material from the award-winning investigation by Brian Deer for The Sunday Times of London, the
UKs Channel 4 TV network and BMJ, the British
Medical Journal, which exposed vaccine
research fraudster Andrew Wakefield | Investigation
summary
Beginning as a routine assignment, Deer's investigation into claims that the MMR vaccine led to autism took off early after an interview with Wakefield's key parent-collaborator, Rosemary Kessick. So as to be sure that the interview was unbiased by any assumptions about the reporter's background, Deer used his middle name to create a pseudonym. Kessick then set out what she said happened to her child in terms that didn't square with Wakefield's research - as noted below by The Washington Post
| |
|
The Post's story, by London correspondent and Pulitzer Prize-winning journalist Glenn Frankel, was printed on Sunday July 11 2004 - just months after Deer's first reports in The Sunday Times. Under the headline "Charismatic Doctor at Vortex of Vaccine Dispute", Frankel's item began with Wakefield's claims as of that time, and included material about Rosemary Kessick, whose son William had become well-known in media reports where Ms Kessick alleged a link between MMR and autism.
At that time, Kessick ran campaign group and was the lead litigant in a British class action lawsuit which had failed in late 2003 for lack of evidence. William was among 12 children included in a research paper which in February 1998 led to a global scare over vaccine safety. In February 2010, this paper would be retracted as a result of Deer's investigation, initially triggered by the interview, and in May 2010 Wakefield would be permanently banned from medicine. |
 |
In his report, Frankel notes with regard to Wakefield's already failing reputation at that time:
Now his credibility has
taken another blow, from a Sunday
Times newspaper report that Wakefield
failed to disclose that his work had
been supported by funds from a group
of parents filing a lawsuit against
the vaccine companies. Wakefield has
vehemently denied any conflict of
interest, but the editor of the
Lancet, a distinguished medical
journal, now says he would not have
published Wakefield's groundbreaking
1998 report had he known about the
funding.
Ten of the 13 physicians involved in
the original report have withdrawn
their support, and the cabinet
secretary in charge of Britain's
national health service has called
for an investigation.
The Wakefield story is about public
health and risk and the abiding
mistrust that many people hold toward
government officials, especially when
it comes to issues of health and
safety. It is also about how the
media can transform complex matters
of public policy into simple
narratives with heroes and villains.
And it is about one charismatic
doctor who contends he holds the key
to unlocking a medical mystery and
that many of his colleagues are
either too craven or too frightened
to seek the truth.
Frankel
describes Wakefield in traditional manner
["tall, square-jawed and
soft-spoken"], and describes him as
once having been "a golden boy in
the medical world". After some
biographical detail, the report returns
to Mrs Kessick:
By the time Kessick came
to see Wakefield with her son
William, he had already begun to
theorize about a link between the
rising numbers of children with
Crohn's disease, an inflammatory
intestinal disorder, and the
introduction of the MMR vaccine a few
years earlier. William's case,
Wakefield says, helped convince him
that there could be a connection
between the vaccine and autism as
well.
Frustrated to the point of rage by
what she saw as a general lack of
understanding in the medical
profession, Kessick had schooled
herself in the disorder. She
discovered that autism comes in many
shapes and sizes, but its most
general characteristic is profound
isolation -- an autism sufferer
cannot communicate with or understand
others. Some children seem to suffer
from autism at birth, while in others
it develops in the first few years of
life.
Kessick also learned that autism
rates were rapidly rising -- although
there is no agreement on exactly how
fast or why. Many experts argue that
improved diagnosis and deeper
awareness among professionals have
led to more accurate and earlier
identification of the problem. Others
contend that the absolute number of
cases is rising, not just medicine's
ability to find them. In their view,
something in the environment must be
to blame.
Based upon William's nightmarish
decline, Kessick was certain that the
MMR vaccine was at least one of the
environmental factors. Most of the
doctors she saw dismissed her as an
obsessed and guilt-stricken mother
looking for an answer to an
unsolvable mystery.
The
Washington Post report describes, among
other things, the study set up at the
Royal Free hospital to test William
Kessick and other children, followed by a
reference to the 1998 press conference
called to launch the now-infamous Lancet
paper.
But other researchers
were failing to reproduce his results
and various epidemiological studies
of large, controlled populations
failed to uncover a link between MMR
and autism. The Institute of Medicine
in Washington, part of the National
Academy of Sciences, has compiled 14
large-scale studies in the United
States, Canada and Europe that all
exonerate the vaccine. Wakefield
suggests each study has been flawed
either because of its methodology or
because its authors massaged the
findings to get the answers they
sought.
David Salisbury, head of Britain's
national immunization program, said
he understands why Wakefield's views
gained traction with the public.
"Unfortunately we have a long
tradition of vaccine scares in this
country," he said in an
interview, "and people no longer
accept the rather patronizing 'Do as
I say because I'm the doctor.'"
Still, says Salisbury, the MMR has
passed every test. "It's now
been looked at by studies from
numerous industrialized countries
conducted in many different ways and
they all come to the same conclusion
-- we can find no evidence of an
MMR-autism link," he said.
The
report then discusses the "single
jabs" issue, sparked by an
unsubstantiated claim by Wakefield at the
press conference that these might be
safer than the triple MMR, before moving
on to the failure of the intended MMR
lawsuit after the Legal Services
Commission "pulled the plug on
funding". Other points follow,
before Frankel turns to London GP Mike
Fitzpatrick.
He says he got involved
in the controversy after the mother
of an autistic child told him she
blamed herself for allowing her child
to receive the triple jab. "What
really annoyed me was Andy Wakefield
setting himself up as spokesman for
the parents when in fact what he was
doing was visiting guilt upon many
parents," said Fitzpatrick, who
has just published a book, "MMR
and Autism: What Parents Need to
Know."
"People are anxious, they're
frightened and so it's easy for many
to adopt the default position and do
nothing," Fitzpatrick said.
Frankel
later turns to Brian Deer, then the Texas
plan:
Last November a Sunday
Times journalist who identified
himself as Brian Lawrence paid a
visit to Kessick's home north of
London. He spent nearly six hours
questioning her about William's
autism, Wakefield and the entire MMR
controversy. Afterward, she said, she
felt like she had been grilled like a
witness under cross-examination. She
said that Lawrence didn't seem to
believe anything she told him.
Her suspicion was not far off.
"Brian Lawrence" was
actually Brian Deer, a prize-winning
investigative journalist with a
reputation for breaking stories about
the pharmaceutical industry. Deer
said he used a false name -- Lawrence
is actually his middle name --
because he didn't want Kessick to
check his web site and find out that
one of his specialties was tracking
down false claims of damage from
vaccines.
Deer said he had planned to attend
the trial of a major MMR lawsuit due
to begin in April. When it was
suspended indefinitely, he decided to
launch his own probe. He found
Kessick, like many of the plaintiffs,
to be sympathetic people but less
than reliable witnesses. He concluded
that they wanted to believe MMR had
caused their children's autism and
that they may have bent the truth to
prove it.
"I took her through her evidence
as she would be asked in court,"
he recalls. After about several
hours, he says, he told her she and
the other plaintiffs could never win
their case.
Wading into the huge volume of
records in the case, Deer discovered
something Wakefield had neglected to
tell the Lancet: that the Royal Free
Hospital had received some $90,000 in
funding from the plaintiffs for
Wakefield's help in doing a study of
10 of the victims. Four of the
plaintiffs, including William
Kessick, were among the dozen
patients included in the Lancet
article.
Rather than showing up at the Royal
Free as consecutive referrals from
disinterested general practitioners,
Deer alleged, the Lancet 12 had been
carefully chosen to prove Wakefield's
theory and help lend credence to the
lawsuit.
Wakefield insisted he had done
nothing wrong -- that the Lancet
study and the legal case had been
kept entirely separate. But Lancet
editor Horton said his former
colleague should have disclosed the
potential conflict before the
original study was published.
"If we had known the conflict of
interest Dr. Wakefield had in this
work, in my judgment it would have
been rejected," Horton told the
BBC.
A few weeks later, 10 of the 13
doctors on the original study issued
a "Retraction of an
interpretation" in which they
declared that "no causal link
was established between MMR vaccine
and autism." Wakefield refused
to sign.
The retraction was "absolute
nonsense, just spin," he says.
"There's absolutely no doubt
they've been under huge pressure and
it's very sad. We did discuss this in
detail and I said, 'Guys, I can't
sign up to this'."
Wakefield lost other allies as well.
John O'Leary, an Irish microbiologist
who has been one of his key
collaborators, pronounced himself
"shocked and disappointed"
that Wakefield had not declared the
potential conflict.
But Wakefield's core supporters, such
as Rosemary Kessick, continue to
believe in him. Robert Sawyer, chief
executive of Visceral, Wakefield's
research group, says donations are
still coming in. But he expects to
move Wakefield's research unit to
Texas over the next few years. The
United States, with its privatized
health care system and
entrepreneurial spirit is much more
fertile ground than Britain for a
medical pioneer like Wakefield,
Sawyer said.
|